spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  E Series 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 9 Apr 2025
Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 25 Mar 2025
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 16 Dec 2024
Tackling the ACL Tear Epidemic in Youth Athletes: A Promising Solution from Arthrex
Devices Orthopaedic
 HSMN NewsFeed - 10 Dec 2024
PENTAX Medical Obtained US FDA 510(k) Clearance for New Models of the PENTAX Medical i20c Video Endoscope Series
Devices Gastroenterology FDA
 HSMN NewsFeed - 31 Oct 2024
Evommune Announces $115 Million Series C Financing to Accelerate Advancement of Clinical-Stage Pipeline Addressing Chronic Inflammatory Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Aug 2024
NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 19 Jul 2024
Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative Metabolic siRNA Pipeline in Clinic and Next Generation RNA Platforms
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 May 2024
CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt(R) System for the Treatment of Normal Pressure Hydrocephalus
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 6 Mar 2024
Sionna Therapeutics Announces $182 Million Series C Financing to Advance Clinical Development of Novel Small Molecules in Cystic Fibrosis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Feb 2024
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 29 Nov 2023
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Aug 2023
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jul 2023
iotaMotion Completes $12M Series A Raise to Accelerate Commercial Expansion of iotaSOFT(R) Insertion System
Devices Surgery Venture Capital
 HSMN NewsFeed - 6 Jul 2023
Append Medical Raises $4.35M in Initial Closing of Extended Series A Round
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 28 Jun 2023
K36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of KTX-1001, First-in-class Inhibitor of MMSET for Treatment of Multiple Myeloma Patients with Genetic Translocation (4;14)
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 6 Jun 2023
Acepodia Secures $100 Million Series D Financing to Advance
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Mar 2023
Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Mar 2023
QurAlis Closes $88 Million Series B Financing to Advance Precision Medicines for Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 6 Mar 2023
Shoulder Innovations Announces Oversubscribed $42 million Series D Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 16 Jan 2023
PENTAX Medical to launch new premium video processor and endoscope series
Devices Product Launch
 HSMN NewsFeed - 9 Jan 2023
SoniVie Raises $60m in Round C Financing, and Appoints New Board Members
Devices Venture Capital
 HSMN NewsFeed - 5 Jan 2023
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Dec 2022
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 8 Dec 2022
Dantari Debuts with $47 Million Series A to Advance Best-in-Class Targeted Medicines for Solid Tumors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 Dec 2022
Apogee Therapeutics Launches with $169 Million to Develop Potentially Best-in-Class Therapies for Immunological and Inflammatory Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Nov 2022
'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals
Devices
 HSMN NewsFeed - 27 Oct 2022
Geistlich Pharma North America, Inc. Acquires Lynch Biologics, LLC, a Biologics and Tissue Engineering Company
Regenerative Medicine Surgery Mergers & Acquisitions
 HSMN NewsFeed - 27 Sep 2022
CraniUS Closes ~$20 Million Series A Funding Round
Devices Drug Delivery Neurosurgery Venture Capital
 HSMN NewsFeed - 15 Sep 2022
Alphyn Biologics Closes $3.3 Million Series A Financing to Advance Breakthrough Atopic Dermatitis Treatment
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 9 Aug 2022
ImmPACT Bio Names Vikram Lamba as Chief Financial Officer and Head of Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 13 Jun 2022
Ablative Solutions, Inc. Announces Completion of the Fourth Tranche of its Series D Preferred Financing Round for Unique Therapeutic Approach to Treating Uncontrolled Hypertension
Devices Venture Capital
 HSMN NewsFeed - 9 Jun 2022
Degron Therapeutics Raises $22M Series A Financing to Accelerate Growth and Expand Molecular-Glue-Based Targeted Protein Degradation Drug Discovery Platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 8 Jun 2022
Smith & Nephew announces first total hip replacement cases on its CORI(TM) Surgical System using RI.HIP MODELER and RI.HIP NAVIGATION
Devices Orthopaedic
 HSMN NewsFeed - 19 May 2022
Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 May 2022
Remix Therapeutics Closes $70 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Mar 2022
4C Medical Technologies Completes $35 Million Series C Financing and Appoints Saravana Kumar as President and CEO
Devices Cardiology Personnel Venture Capital
 HSMN NewsFeed - 30 Mar 2022
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 29 Mar 2022
Medline and Hologenix Partner on New Curad Performance Series Line Powered By Celliant
Devices Orthopaedic Distribution
 HSMN NewsFeed - 15 Mar 2022
3Spine, Inc. Raises $33M in Private Series C Round
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 28 Feb 2022
After Successful Launch of Titan SGS(R) Surgical Stapler, Standard Bariatrics, Inc. Achieves Final Series B Funding Early
Devices Surgery Venture Capital
 HSMN NewsFeed - 18 Jan 2022
Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 30 Dec 2021
Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Dec 2021
Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor
Devices Venture Capital
 HSMN NewsFeed - 1 Dec 2021
Curie Therapeutics Raises $75 Million Financing to Further its Mission of Transforming Cancer Care with Precision Radiopharmaceuticals
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Nov 2021
Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBV
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Aug 2021
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Aug 2021
Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
Devices Surgery Venture Capital
 HSMN NewsFeed - 11 Aug 2021
GentiBio Announces $157M Series A Financing to Advance Engineered Regulatory T cells as Transformative Therapeutics with Potential to Restore Immune Tolerance and Durably Treat Autoinflammation
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Aug 2021
LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 while Advancing Portfolio Assets
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 5 Aug 2021
Aardvark Therapeutics, Inc., Completes $29m Series B Funding Led By Sorrento Therapeutics And Including Existing Investors And The Foundation For Prader-Willi Research
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Jul 2021
MicroPort(R) Cardiac Rhythm Management Business Announces US$150 Million Series C Investment
Devices Cardiology Venture Capital
 HSMN NewsFeed - 22 Jul 2021
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Jul 2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jul 2021
Theolytics expands Series A financing and welcomes M Ventures as a new investor
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Jul 2021
Sirnaomics Secures $105 Million in Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 May 2021
Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 11 May 2021
Nuvalent Completes $135 Million Series B Financing to Advance Portfolio of Novel Precisely Targeted Kinase Inhibitors for Treatment-Resistant Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 May 2021
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 7 May 2021
LumiThera Presents Valeda Treatment Benefits for Photobiomodulation in Early Patients with Diabetic Retinopathy and Macular Edema
Devices Ophthalmology
 HSMN NewsFeed - 5 May 2021
BridGene Biosciences Announces $12 Million Series A Financing to Advance the Company's Proprietary Chemoproteomic Platform and Pipeline of Oncology Programs
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 13 Apr 2021
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Apr 2021
S4 Medical Closes Series A Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 24 Feb 2021
Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 24 Feb 2021
Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Feb 2021
Cyteir Therapeutics Secures $80 Million in Series C Financing to Advance Clinical Trials of Lead RAD51 Program
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 Jan 2021
Dominion Aesthetic Technologies Closes $23.7 Million Series B Financing to Accelerate the Commercialization of EON
Devices Venture Capital
 HSMN NewsFeed - 11 Jan 2021
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jan 2021
Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 24 Dec 2020
Interscope Announces FDA De Novo Marketing Authorization of the EndoRotor(R) System for Direct Endoscopic Necrosectomy (DEN)
Devices Surgery FDA
 HSMN NewsFeed - 16 Dec 2020
Vivace Therapeutics Announces $30 Million Series C Financing to Fund Clinical Programs Targeting the Hippo Pathway
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 16 Dec 2020
Neuron23(TM) Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 8 Dec 2020
Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Processing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Nov 2020
Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 18 Nov 2020
Umoja Biopharma Launches with $53M Series A Financing to Develop Fully Integrated, Scalable, In Vivo Immunotherapy Platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Nov 2020
CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Oct 2020
Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical Stage Research in Therapeutics Designed to Restore Immune Homeostasis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Sep 2020
BioShin, Biohaven's Asia-Pacific Subsidiary, Raises $60M in Series A Funding to Advance Neuroscience Pipeline in Asia-Pacific Region
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 14 Sep 2020
Attralus Launches with $25 Million Series A Financing from venBio Partners to Transform Treatment for Patients with Systemic Amyloidosis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Sep 2020
Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion
Devices Venture Capital
 HSMN NewsFeed - 24 Aug 2020
Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 20 Aug 2020
Garwood Medical Devices Announces Series C Funding
Devices Venture Capital
 HSMN NewsFeed - 8 Jul 2020
LumiThera Closes Series C Round of Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 17 Jun 2020
Proprio Raises $23 Million in Series A Funding Led by DCVC
Devices Surgery Venture Capital
 HSMN NewsFeed - 16 Jun 2020
Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 8 Jun 2020
HistoSonics Announces $40 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 21 May 2020
HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 May 2020
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 May 2020
Travecta Therapeutics Secures $15 Million in Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 12 May 2020
Kriya Therapeutics announces $80 million Series A financing to advance gene therapies for highly prevalent serious diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 12 May 2020
CytoSorb(R) is E.U. Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery
Devices Regulatory
 HSMN NewsFeed - 28 Apr 2020
Scopio Labs Closes $16 Million Series B Round to Expand Commercial Rollout of Automated Microscopy Solutions
Devices Venture Capital
 HSMN NewsFeed - 27 Apr 2020
Actym Therapeutics Raises $34 Million Series A
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 23 Apr 2020
SwanBio Therapeutics Announces Series A Expansion to Fund its Lead Program and Grow Pipeline in Gene Therapy for Neurological Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 1 Apr 2020
Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 26 Mar 2020
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Mar 2020
Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Mar 2020
Apexigen Completes $123 Million Series C Financing To Advance Clinical Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Feb 2020
Cerus Endovascular Successfully Completes Series B Financing and Receives U.S. FDA Approval for its First Microcatheter
Devices Interventional Neurology Venture Capital FDA
 HSMN NewsFeed - 13 Feb 2020
Results Validating the Versatility of NuVasive's MaXcess(R) Retractor in Prone Single-Position XLIF(R) and Posterior Fixation Published in The European Spine Journal
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 7 Feb 2020
Elios Therapeutics Presents New Phase IIb Data for Personalized Cancer Vaccine in High-Risk Melanoma Patients at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jan 2020
Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Jan 2020
iOnctura Raises EUR 15 Million in Series A Financing to Progress its Pipeline into Clinical Development
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 10 Jan 2020
Inflammatix Announces $32 Million in Series C Funding
Diagnostics Venture Capital
 HSMN NewsFeed - 3 Jan 2020
Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 10 Dec 2019
Shoulder Innovations Announces FDA 510(k) Clearance For InSet Plus(TM) Augmented Glenoids For Total Shoulder System
Devices Orthopaedic FDA
 HSMN NewsFeed - 5 Dec 2019
Black Diamond Therapeutics Closes $85 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 20 Nov 2019
Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicines
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 7 Nov 2019
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 6 Nov 2019
Cadence Neuroscience Secures $15 Million in Series A Financing for Commercialization of Epilepsy Therapy Licensed from Mayo Clinic
Devices Neurology Venture Capital
 HSMN NewsFeed - 1 Nov 2019
CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom
Devices
 HSMN NewsFeed - 29 Oct 2019
Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Oct 2019
Tenaya Therapeutics Closes $92 Million Series B Financing
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 3 Oct 2019
Turn Therapeutics(TM) Closes Series B Round to Fuel Lead Atopic Dermatitis Program Trial and Pipeline Expansion
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 13 Sep 2019
Published Study Finds 9/10 Chronic Wound Patients Likely to Have Received More Appropriately Triaged Care with Information from the MolecuLight i:X(R) Imaging Device
Devices Wound Care
 HSMN NewsFeed - 10 Sep 2019
Pharvaris Announces $66 Million Series B Financing to Advance the Clinical Development of an Oral Therapy for Hereditary Angioedema
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Sep 2019
MedShape Announces Commercial Launch of DynaNail Mini(TM) for Subtalar Fusion
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 26 Aug 2019
Atonarp Inc. Announces $33 Million Series C Funding Round Completion
Diagnostics Venture Capital
 HSMN NewsFeed - 7 Aug 2019
Glycomine, Inc. Announces $33 Million Series B Financing to Advance its Therapy for a Congenital Disease of Glycosylation
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 Jul 2019
Immunicom Secures $11 Million in Series B Investment Round
Devices Venture Capital
 HSMN NewsFeed - 26 Jun 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 24 Jun 2019
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 17 Jun 2019
FDA approves new cochlear implant with easier access to MRI and expanded connectivity ready for Google's direct streaming to Android smartphones
Devices FDA
 HSMN NewsFeed - 13 Jun 2019
Medical Fish Skin Company Kerecis Limited Completes $16 Million Series C Offering
Regenerative Medicine Wound Care Venture Capital
 HSMN NewsFeed - 20 May 2019
Reneo Pharmaceuticals Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 May 2019
PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to-Treat Lower Extremity Chronic Wounds Using SkinTE
Regenerative Medicine Wound Care
 HSMN NewsFeed - 17 Apr 2019
Aidoc Raises $27 Million to Expand Its Life-saving Artificial Intelligence Solutions by 700% Across Medical Imaging
Devices Radiology Venture Capital
 HSMN NewsFeed - 8 Apr 2019
ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products
Devices Wound Care Distribution
 HSMN NewsFeed - 14 Mar 2019
Clinical Study Demonstrates Long Term IOP Reduction with the OMNI(R) Surgical System Predicate Device (TRAB(R)360) in Micro-Invasive Glaucoma Surgery
Devices Ophthalmology
 HSMN NewsFeed - 5 Mar 2019
MedShape Announces Commercial Launch of DynaClip(TM) Bone Staple
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 20 Feb 2019
Neovasc Provides Corporate Update
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 14 Feb 2019
Burning Rock announces the completion of the Series C financing of RMB 850 million and strives to build an international leading tumor precision medicine brand
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 11 Feb 2019
Pierangeli Clinic Initiates Program Providing Neovasc Reducer(TM) Procedure to Italian Patients with Refractory Angina
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Jan 2019
Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 20 Dec 2018
Kypha Secures $4M Series A Funding to Accelerate First-in-Class Diagnostic Platform Commercialization
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Dec 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Dec 2018
TIGR(R)Matrix shows promising results when used for incisional hernia prevention in septic patients undergoing laparoscopy
Devices Surgery
 HSMN NewsFeed - 28 Nov 2018
MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Nov 2018
Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 25 Oct 2018
FogPharma Appoints Dr. Barbara Weber to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2018
Gauss raises $20 million in Series C from Northwell Health and SoftBank Ventures Korea for AI-Enabled Platform for the Operating Room
Devices Surgery Monitoring Venture Capital
 HSMN NewsFeed - 3 Oct 2018
Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer(TM)
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Oct 2018
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 25 Sep 2018
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2018
Miracor Medical closes final tranche of Series-D, bringing the round to €30M
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 23 Aug 2018
Rakuten Aspyrian Raises $150 Million in Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 17 Jul 2018
Candela Announces FDA Clearance Of Vbeam(R) Prima
Devices Dermatology FDA
 HSMN NewsFeed - 20 Jun 2018
Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Jun 2018
Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo
Biopharmaceuticals Gastroenterology Venture Capital
 HSMN NewsFeed - 11 Jun 2018
Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update
Devices Cardiology Personnel
 HSMN NewsFeed - 25 May 2018
Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2018
FogPharma Secures $66 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 May 2018
EIP Pharma Secures $20.5 Million in Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 15 May 2018
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 14 May 2018
Ansun BioPharma secures $85 million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 May 2018
Refuge Biotechnologies Completes $25 Million Series B Financing, Appoints CSO to Advance the Development of Intelligent Cell Therapies in Oncology
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 5 Apr 2018
Eidos Therapeutics completes $64M Series B financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Apr 2018
Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Mar 2018
DarioHealth Receives U.S. FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 6 Mar 2018
Smith & Nephew announces full commercial release of JOURNEY(TM) II XR Total Knee Arthroplasty
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 22 Feb 2018
Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 6 Feb 2018
eNeura, Inc. Announces Series D Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 24 Jan 2018
Neuspera Medical Announces Initial Close of $26M Series B Equity Financing
Devices Neurology Venture Capital Personnel
 HSMN NewsFeed - 4 Jan 2018
Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 7 Dec 2017
Epidarex Capital Portfolio Company Harpoon Medical Acquired By Edwards Lifesciences
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 7 Dec 2017
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 29 Nov 2017
electroCore Completes $70 Million Series B Funding Round
Devices Neurology Venture Capital
 HSMN NewsFeed - 29 Nov 2017
Frazier-backed Mavupharma secures $20M in Series A financing to fund STING program
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 29 Nov 2017
Codiak BioSciences Closes $76.5 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Nov 2017
Outpost Medicine Appoints Scott Byrd as Chief Executive Officer and Raises $20 Million in Series A Financing Extension
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 15 Nov 2017
Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs
Devices Cardioloy Venture Capital
 HSMN NewsFeed - 31 Oct 2017
LumiThera Closes Series B Round of Financing
Devices Ophthalmology Venture Capital Personnel
 HSMN NewsFeed - 6 Oct 2017
Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 3 Oct 2017
EnteroMedics Announces Acquisition Of ReShape Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 29 Aug 2017
ARMO BioSciences Raises $67 Million in a Series C-1 Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 28 Aug 2017
MedGenome Secures $30 Million Series C Funding Led by Sequoia India and Sofina
Diagnostics Venture Capital
 HSMN NewsFeed - 23 Aug 2017
Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Aug 2017
VentureMed Group Raises $15 Million Series B Equity Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 2 Aug 2017
Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP, Increasing Total Raised in Series C to US$38 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Jul 2017
PreciThera, Inc. Completes $36 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Jul 2017
Cochlear Introduces the World's First Made-for-iPhone Cochlear Implant Sound Processor
Devices Product Launch
 HSMN NewsFeed - 24 Jul 2017
eFFECTOR Therapeutics Completes $38.6 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 18 Jul 2017
Menlo Therapeutics Raises $50M
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jul 2017
BD Transforms Microbiology Urine Testing
Diagnostics Product Launch
 HSMN NewsFeed - 17 Jul 2017
Enterin Inc. Raises $12.7 Million in Series A Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 21 Jun 2017
410 Medical Receives Funding from Triangle Venture Alliance (TVA) - A Newly Formed Network Based on Angel Investors tied to Leading North Carolina Universities
Devices Venture Capital
 HSMN NewsFeed - 8 Jun 2017
TissuGlu(R) Surgical Adhesive enables drain-free recovery in patients undergoing DIEP flap breast reconstruction
Devices Surgery
 HSMN NewsFeed - 22 May 2017
Telemedicine Innovator Lemonaid Health Raises $11 Million in Series A Funding
Devices Venture Capital
 HSMN NewsFeed - 15 May 2017
Formation Biologics Announces Dosing of First Patient in a Phase I/IIa Trial of AVID100, Closing of Series B Financing, and Appointment of Dr. Anthony Tolcher to its Board of Directors
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 25 Apr 2017
AltheaDx Closes $27 Million Series D Financing
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 4 Apr 2017
NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 14 Mar 2017
Peloton Therapeutics Completes $22.2 Million Private Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Jan 2017
Macrophage Pharma Raises £9 Million in Series A Financing and Acquires Immune-oncology Technology Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jan 2017
GRAIL Plans to Raise in Excess of $1B in Series B Funding
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 3 Jan 2017
Ascletis Raises US$100 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Dec 2016
Study Published in Journal of Glaucoma Evaluates a Single Glaukos iStent(R) Trabecular Micro-Bypass Stent as a Standalone Procedure
Devices Ophthalmology
 HSMN NewsFeed - 30 Nov 2016
Novogene Completes USD $75 Million B Round Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 24 Nov 2016
Kymab Secures US$100 Million Series C Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Nov 2016
Evena Medical Launches Advanced Mobile Ultrasound Medical Imaging System at MEDICA 2016
Devices Product Launch
 HSMN NewsFeed - 2 Nov 2016
Boston Scientific Announces Initial U.S. Commercial Performance Of The WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 2 Nov 2016
Turnstone Biologics Raises $41.4 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 25 Oct 2016
Miracor Receives Additional Funding in Series-C Closing to Expand Clinical and Commercial Activities with the PiCSO(R) Impulse System
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 18 Oct 2016
True North Therapeutics Announces $45 Million Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Sep 2016
Peloton Therapeutics Completes $52.4 Million Private Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Sep 2016
Eyevensys Announces Series A Extension Bringing Total Capital Raised to €9 Million
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 5 Sep 2016
Dynavax Provides Regulatory Update on HEPLISAV-B
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Sep 2016
Avita Medical's Regenerative Skin Technology Significantly Reduces Burn Scars and Healing Time
Devices Regenerative Medicine
 HSMN NewsFeed - 16 Aug 2016
Tioma Therapeutics Announces $86 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 Aug 2016
Bioniz Therapeutics Closes Series A Financing and Appoints David Pyott as Chairman of the Board of Directors
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 5 Jul 2016
NightBalance Closes EUR 12.5 Million Series B Financing to Support Commercial Rollout in Europe and Enter the U.S. Market with Its Innovative Sleep Apnea Device
Devices Venture Capital Personnel
 HSMN NewsFeed - 14 Jun 2016
VitalConnect Announces Closure of $25 Million of Financing
Devices Monitoring Venture Capital
 HSMN NewsFeed - 18 May 2016
St. Jude Medical Announces European Launch of the Latest in PressureWire Guidewire Technology to Measure Pressure Differences Across Narrowed Coronary Arteries
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 16 May 2016
Caribou Biosciences Raises $30 Million in Series B Funding
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 May 2016
Graybug Vision Announces $44.5 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 19 Apr 2016
DalCor Pharmaceuticals Completes $150 Million Financing
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 14 Apr 2016
RefleXion Medical Raises $46 Million Series B Financing Led by KCK Group
Devices Oncology Venture Capital Personnel
 HSMN NewsFeed - 12 Apr 2016
iSTAR Medical Secures €10 Million Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 22 Mar 2016
Acutus Medical Completes $75 Million Series C Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 7 Mar 2016
Avita Medical Announces U.S. FDA Approval for Increase in Compassionate Use of ReCell(R) Patient Cases
Regenerative Medicine Wound Care Dermatology FDA
 HSMN NewsFeed - 24 Feb 2016
Forty Seven Inc. Completes $75M Series A Financing and Licenses Technology from Stanford University to Advance Next Generation Immuno-Oncology Programs
Biopharmaceuticals Oncology Venture Capital Licensing
 HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 3 Feb 2016
Silk Therapeutics Raises $6 Million In Series A2 Financing
Dermatology Venture Capital
 HSMN NewsFeed - 3 Feb 2016
BioDirection, Inc. Closes $4 Million Series B Financing
Devices Diagnostics Neurology Venture Capital
 HSMN NewsFeed - 26 Jan 2016
Codiak BioSciences Closes $61 Million Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 19 Jan 2016
HiberGene Closes First Tranche of Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 11 Jan 2016
Iconic Therapeutics Closes Series C Financing With New and Existing Investors
Biopharmaceuticals Oncology Ophthalmology Venture Capital
 HSMN NewsFeed - 7 Jan 2016
Exosome Diagnostics Completes $60 Million Series B Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 7 Jan 2016
C4 Therapeutics Launches with $73 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 22 Dec 2015
eFFECTOR Therapeutics Raises $40 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 18 Dec 2015
Navitor Pharmaceuticals Announces $33 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Dec 2015
AltheaDx Completes $30M Series C Financing
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 9 Dec 2015
Allena Pharmaceuticals Raises $53 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Dec 2015
Avita Medical Highlights Report of 63% Decreased Length of Hospital Stay for Patients With Large Burns Treated Using ReCell(R)
Regenerative Medicine Wound Care
 HSMN NewsFeed - 3 Dec 2015
True North Therapeutics Announces $40 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Dec 2015
Kesios Therapeutics Raises £19 Million in Series A Financing
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 12 Nov 2015
RetroSense Therapeutics Raises $6 million in an Over-Subscribed Series B Financing to Advance Clinical Development of Lead Product RST-001 for Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 23 Oct 2015
Sequana Medical AG Raises CHF 9 million (USD 9.3M) in a Series C Extension
Devices Venture Capital
 HSMN NewsFeed - 21 Oct 2015
Arvinas Secures $41.6M Series B Financing - Appoints New Board Members
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Oct 2015
Avita Medical Highlights ReCell(R) Findings Published in Journal of Cranio-Maxillo-Facial Surgery
Regenerative Medicine Wound Care
 HSMN NewsFeed - 14 Oct 2015
Galera Therapeutics Raises $37 Million in Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Sep 2015
Precision NanoSystems Raises $13.4M in Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Sep 2015
Selecta Announces $38 Million Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Aug 2015
Channel Medsystems Secures $22 Million Series C Financing Led by Third Point Ventures
Devices Venture Capital
 HSMN NewsFeed - 18 Aug 2015
WAVE Life Sciences Raises $66 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Aug 2015
Ovid Therapeutics Completes Oversubscribed $75 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 10 Aug 2015
Turing Pharmaceuticals Announces $90 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jul 2015
Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology
Devices Interventional
 HSMN NewsFeed - 27 Jul 2015
Castle Biosciences Closes $11.7 Million Tranche of $20 Million Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 23 Jul 2015
SutroVax raises $22 million in Series A
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 22 Jul 2015
KalVista Pharmaceuticals Raises $33 Million to Advance Development of Novel Plasma Kallikrein Inhibitors in Diabetic Macular Edema and Hereditary Angioedema
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Jun 2015
Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy
Devices Neurology Interventional Venture Capital
 HSMN NewsFeed - 16 Jun 2015
Kezar Life Sciences Closes $23M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jun 2015
XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 19 May 2015
Debiopharm International SA Announces Phase III Positive Results for Triptorelin 6-month Formulation in the Management of Central Precocious Puberty (CPP)
Biopharmaceuticals
 HSMN NewsFeed - 7 Apr 2015
True North Therapeutics Announces $35 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Mar 2015
Nimbus Therapeutics Raises $43 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Feb 2015
Cidara Therapeutics Completes $42 Million Private Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jan 2015
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin(TM) Platform for Cancer Therapeutics
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 Jan 2015
Aduro Biotech Closes $51.4 Million Series D Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 Dec 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Nov 2014
Monteris Medical Announces $30 Million Equity Financing
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 23 Oct 2014
Quartet Medicine Launches with $17 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Oct 2014
Viamet Announces $60 Million Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Sep 2014
Ivantis Raises Additional $25 MM, Increasing Series B to $71 MM
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 10 Sep 2014
Harpoon Medical, Inc. Announces $3.75M Series A Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 28 Aug 2014
Armetheon Completes $7.0 Million Series A Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 27 Aug 2014
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Aug 2014
Advanced Catheter Therapies Announces Series B Equity Financing
Devices Venture Capital
 HSMN NewsFeed - 30 Jul 2014
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 16 Jul 2014
Virobay Completes $8 Million Series B Preferred Stock Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Jun 2014
Tyrogenex Raises $15M in Series D Financing from Brace Pharma, US Investment Arm of EMS S/A
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 19 Jun 2014
Navitor Pharmaceuticals Launches with $23.5 Million Series A Financing for Novel Drug Discovery Targeting Cellular Nutrient Signaling to Treat Chronic Diseases and Rare Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jun 2014
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jun 2014
Benvenue Medical Secures $64 Million Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 4 Jun 2014
Ultrasonic BoneScalpel(TM) Making Spine Surgery Safe and Efficient
Devices Surgery
 HSMN NewsFeed - 14 May 2014
Medrobotics Closes $26 Million Series E Financing
Devices Surgery Venture Capital
 HSMN NewsFeed - 17 Apr 2014
Nora Therapeutics Announces $18 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Apr 2014
EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Mar 2014
Kolltan Pharmaceuticals Obtains $60 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Mar 2014
Lumena Pharmaceuticals Raises $45 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Mar 2014
Exosome Diagnostics Raises $27 Million in Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 21 Feb 2014
Fish-Skin Medical Company Completes Funding Round
Regenerative Medicine Wound Care Venture Capital
 HSMN NewsFeed - 11 Feb 2014
Lithera Announces Final Closing of $35.6 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Feb 2014
Mylan Launches First Trastuzumab Biosimilar, Hertraz(TM), in India
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 9 Jan 2014
Covidien, Lightstone Ventures, New Enterprise Associates Announce Series A Investment in FIRE1
Devices Venture Capital Personnel
 HSMN NewsFeed - 3 Jan 2014
Metabolon Closes $15 Million Series E Financing
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 2 Jan 2014
NeXeption, LLC Forms New Company Alexar Therapeutics, Inc. to Develop Novel LXR Agonist Portfolio for Dermatologic Indications; Raises $21.5 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 19 Dec 2013
Vensun Pharmaceuticals, Inc. Completes Series B Financing
Biopharmaceuticals Generics Venture Capital
 HSMN NewsFeed - 18 Dec 2013
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 10 Dec 2013
Invitae Completes $40 Million Series E Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 3 Dec 2013
Xlumena Closes Series C Financing; Focuses on Expanding Global Commercial Presence and Obtaining FDA Clearance
Devices Interventional Gastroenterology Venture Capital
 HSMN NewsFeed - 12 Nov 2013
Alliqua Receives $1M from Crossover Healthcare Fund, LLC to Pursue Key Wound Care Initiatives
Devices Wound Care
 HSMN NewsFeed - 11 Nov 2013
Growing Body of Evidence Supports V.A.C. VeraFlo(TM) Therapy Changing How Clinicians Approach Treating Wounds
Devices Wound Care
 HSMN NewsFeed - 6 Nov 2013
Lion Biotechnologies Completes $23.3 Million Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Oct 2013
CVRx Closes $12 Million Additional Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 22 Oct 2013
BioReference Laboratories, Inc. Sued by Myriad Genetics, Confident in Its Position
Diagnostics Oncology Litigation
 HSMN NewsFeed - 22 Oct 2013
Sideris Pharmaceuticals Completes $32 Million Equity Financing and Signs Agreement With Global Pharmaceutical Company
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 Oct 2013
SAGE Therapeutics Secures $20M Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 1 Oct 2013
Russ Trenary to Lead InnFocus, Inc.
Devices Ophthalmology Personnel
 HSMN NewsFeed - 4 Sep 2013
$30 Million Secured in iPierian Financing and Series A Financing for Launch of Spin-out, True North Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Aug 2013
ObsEva SA Announces CHF 32 Million Series A Funding From Leading Venture Capital Firms and a License Agreement With Merck Serono
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 27 Aug 2013
Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 20 Aug 2013
DermTech Raises $5.6 Million in Series B Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 20 Aug 2013
Applied Proteomics Inc. Completes $28 Million Series C Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 31 Jul 2013
Advanced Circulatory Closes $2 Million Bridge Financing
Devices Venture Capital
 HSMN NewsFeed - 31 Jul 2013
Hansen Medical Enters Into Agreement With Investors to Receive up to $93 Million in Equity Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 23 Jul 2013
JenaValve Raises $62.5 Million In Venture Funding
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 25 Jun 2013
Multiplicom Appoints Dr. Ian Gilham as Chairman of the Board
Diagnostics Personnel
 HSMN NewsFeed - 17 Jun 2013
Minimally Invasive Devices Adds $2.5 Million to its Series B
Devices Surgery Venture Capital
 HSMN NewsFeed - 20 May 2013
Karyopharm Therapeutics Raises $48.2 Million in Series B Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 6 May 2013
Arrowhead Closes $36 Million Private Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Apr 2013
Elekta to Highlight Clinical and Safety Advantages of Gamma Knife Radiosurgery at 2013 AANS Meeting
Devices Neurosurgery Oncology
 HSMN NewsFeed - 26 Mar 2013
Misonix BoneScalpel(TM) Subject of New Clinical Paper Focused on Spine Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 25 Mar 2013
Novira Therapeutics Completes $25 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 18 Mar 2013
Cytomedix Announces Centers for Medicare & Medicaid Services (CMS) Issuance Of Reimbursement Coding for Autologous PRP in Chronic Non-Healing Wounds
Regenerative Medicine Wound Care Reimbursement
 HSMN NewsFeed - 11 Mar 2013
Gore Launches Lower Profile GORE(R) EXCLUDER(R) AAA Endoprosthesis Contralateral Leg Components in US and Europe
Devices Interventional Product Launch
 HSMN NewsFeed - 26 Feb 2013
Brickell Biotech Announces $7M Series B Financing to Fund Development of Novel Dermatology Treatments
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 14 Feb 2013
Elcelyx Therapeutics Completes $20 Million Series C Financing to Advance NewMet and Lovidia
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 Feb 2013
CyVek, Inc. Secures $5.5 Million in Series D Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 7 Jan 2013
RusnanoMedInvest and Domain Associates Invest In Neurology Company Marinus Pharmaceuticals
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 18 Dec 2012
Blend Therapeutics Closes $16 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Dec 2012
Naurex Completes $38 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 4 Dec 2012
Kona Medical Closes $40 Million Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 27 Nov 2012
Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Nov 2012
Toshiba’s New MR Series Offers Technology Investment for the Future
Devices Radiology
 HSMN NewsFeed - 19 Nov 2012
AGTC Secures $37.5M Series B Funding
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 13 Nov 2012
Pearl Therapeutics Raises $65 Million Series D to Start PT003 Phase 3
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Nov 2012
Auspex Pharmaceuticals Closes $25 Million Series D Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 8 Nov 2012
joimax(R), EndoSphere Spine, LLC and the University of Toledo, Ohio, Have Signed a License Agreement on Endoscopic Cage Technologies
Devices Neurosurgery Orthopaedic Licensing
 HSMN NewsFeed - 28 Oct 2012
Accuray Launches New TomoTherapy(R) H(TM) Series Featuring TomoEDGE(TM)
Devices Oncology
 HSMN NewsFeed - 15 Oct 2012
Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 8 Oct 2012
Gliknik Raises $4.9 Million In Series B Financing Led By Baxter Ventures
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 8 Oct 2012
Integra LifeSciences Features New MAYFIELD(R) Composite Series Cranial Stabilization Products at the Congress of Neurological Surgeons Annual Meeting
Devices Neurosurgery
 HSMN NewsFeed - 4 Oct 2012
Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Oct 2012
Study Shows NeurOptics Pupillometers Reliably Measure Pupillary Light Reflex, Helping to Predict Survival and Neurological Outcome after Cardiac Arrest
Devices Neurology
 HSMN NewsFeed - 20 Sep 2012
Innovative Pulmonary Solutions Names Dennis Wahr, M.D., as President and CEO and Announces Series B Financing Milestone
Devices Venture Capital Personnel
 HSMN NewsFeed - 5 Sep 2012
Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cells Under Compassionate Use
Regenerative Medicine Oncology
 HSMN NewsFeed - 24 Aug 2012
Sapheon Completes First Closing in Series B Preferred Offering; Dr. Aaron Berez Joins Board of Directors
Devices Venture Capital Personnel
 HSMN NewsFeed - 22 Aug 2012
Toshiba Receives FDA Clearance for the New 8- and 32-Channel Titan 1.5T MR Systems
Devices Radiology FDA
 HSMN NewsFeed - 6 Aug 2012
Cytomedix Announces Medicare Coverage for Autologous PRP Gel in Chronic Wound Care
Regenerative Medicine Wound Care Reimbursement
 HSMN NewsFeed - 24 Jul 2012
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Jun 2012
Benvenue Medical Secures $25 Million Series D Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 13 Jun 2012
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 30 May 2012
AssureRx Health Raises $12.5 Million Series C Financing
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 16 May 2012
Mitralign Raises $35 Million Series D Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 8 May 2012
Sutro Closes $16.5 Million Second Tranche of Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 May 2012
Boston Scientific Announces FDA Approval and First U.S. Implant of New Devices To Treat Bradycardia
Devices Cardiology FDA
 HSMN NewsFeed - 2 May 2012
EKOS Corporation Announces Two More Pulmonary Embolism Clinical Studies
Devices Drug Delivery
 HSMN NewsFeed - 24 Apr 2012
miRagen Therapeutics Secures $20 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Apr 2012
ZipLine(TM) Medical announces appointment of John R. Tighe as CEO
Devices Surgery Venture Capital Personnel
 HSMN NewsFeed - 9 Apr 2012
DA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline
Biopharmaceuticals Radiology Neurology FDA
 HSMN NewsFeed - 2 Apr 2012
MolecularMD Closes $6 Million Series B Financing and Announces Ensuing Growth Initiatives
Diagnostics Venture Capital
 HSMN NewsFeed - 21 Mar 2012
Myoscience Closes $33 Million Series D Financing
Devices Venture Capital
 HSMN NewsFeed - 12 Mar 2012
HemaQuest Pharmaceuticals Raises $13 Million in Series B Extension Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Feb 2012
MelaFind(R) Results Improve Detection of Melanoma, Study Shows
Devices Dermatology Oncology
 HSMN NewsFeed - 16 Feb 2012
Mnemosyne Pharmaceuticals, Inc. Completes $5.4 Million Series A Round to Support Drug Discovery Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Feb 2012
ALung Technologies Raises $10 Million in Series B Financing
Devices Venture Capital
 HSMN NewsFeed - 27 Jan 2012
Sorin Group Opens New International Training Center for Healthcare Professionals
Devices
 HSMN NewsFeed - 13 Dec 2011
Sotera Wireless Completes $12.2 Million Series D Financing, Signs Agreement with Cerner
Devices Monitoring Venture Capital
 HSMN NewsFeed - 28 Nov 2011
CorMedix Appoints Pharmaceutical Veteran, Matthew Duffy to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Nov 2011
Pfizer to Acquire Excaliard Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Nov 2011
Pivot Medical Raises $32 Million in Series C Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 3 Nov 2011
Tangent Medical Closes $4.5 Million Series A Financing
Devices Venture Capital Personnel
 HSMN NewsFeed - 1 Nov 2011
Sensors for Medicine and Science Raises $54.1 Million Series D Financing
Devices Monitoring Venture Capital
 HSMN NewsFeed - 27 Oct 2011
ULURU Inc. Announces Additional Data Supporting Altrazeal(R) Use in Diabetic Foot Ulcers
Devices Wound Care
 HSMN NewsFeed - 20 Sep 2011
CardioKinetix Inc. Raises $44 Million in Series E Financing
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 12 Sep 2011
Valeritas Announces $150 Million Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 1 Aug 2011
Intuity Medical Closes $76 Million Series D Financing
Devices Venture Capital
 HSMN NewsFeed - 18 Jul 2011
SARcode Bioscience Completes $44 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jul 2011
Verastem Raises $32 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jun 2011
Sheila Gujrathi, M.D. Named Chief Medical Officer of Receptos
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2011
Tenex Health Announces $5 Million in Series A Financing to Commercialize the TX1(TM) System
Devices Surgery Venture Capital
 HSMN NewsFeed - 27 Jun 2011
OncoSec Closes $3.0 Million Private Placement
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Jun 2011
TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 17 Jun 2011
K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus
Biopharmaceuticals Generics
 HSMN NewsFeed - 1 Jun 2011
Esperance Pharmaceuticals Completes $7.5 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 16 May 2011
Neuronetics, Inc. Raises $30 Million in Series E Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 28 Apr 2011
Cianna Medical Closes $12 Million in Funding for SAVI Breast Cancer Treatment
Devices Oncology Venture Capital
 HSMN NewsFeed - 27 Apr 2011
PhaseBio Pharmaceuticals, Inc. Announces the Appointment of Kathryn J. Gregory Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2011
MyHealthDIRECT Receives $4 Million in Series B Investment Funding
Healthcare Information Technology Venture Capital
 HSMN NewsFeed - 15 Feb 2011
ArthroCare Receives FDA Clearance for Spartan 5.5 Needled Suture Implant
Devices Orthopaedic FDA
 HSMN NewsFeed - 4 Feb 2011
FDA Approves Makena, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Feb 2011
Spine Wave Announces Completion of $17.5M Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 5 Jan 2011
TetraLogic Closes $23 Million Second Tranche of Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 4 Jan 2011
Sera Prognostics Closes $1.4 Million Series A-1 Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 9 Dec 2010
CE Mark Announced for ArthroCare’s WoundWand(TM) Debridement Device
Devices Wound Care Regulatory
 HSMN NewsFeed - 8 Dec 2010
Sequenta, Inc. Secures $13 Million in Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 2 Dec 2010
PhaseBio Pharmaceuticals Reaches Key Milestones and Receives $15 Million to Complete Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Dec 2010
Accelerator Corporation Finances Eleventh Startup with Acylin Therapeutics, Inc.
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Nov 2010
New Data on H.P. Acthar(R) Gel in the Treatment of Nephrotic Syndrome Presented at the American Society of Nephrology 43rd Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 11 Nov 2010
Arbor Pharmaceuticals Completes $34.8 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Nov 2010
Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Nov 2010
ArthroCare Receives FDA Clearance for SpeedFix
Devices Orthopaedic FDA
 HSMN NewsFeed - 1 Nov 2010
Vascular Pathways Inc. Completes Series B Financing
Devices Venture Capital
 HSMN NewsFeed - 29 Oct 2010
Roche Introduces Immunoassay Module for cobas(R) 8000 Modular Analyzer Series In U.S.
Diagnostics
 HSMN NewsFeed - 28 Oct 2010
ArthroCare Receives FDA Clearance for Spartan PEEK Suture Implant
Devices Surgery Orthopaedic
 HSMN NewsFeed - 21 Oct 2010
Dicerna Pharmaceuticals Announces Second Close of Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Oct 2010
Cerenis Therapeutics raises additional €10 million to close €50 million Series C financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Oct 2010
K-V Pharmaceutical Company Announces Establishment of New Generic Marketing Subsidiary and Senior Executive Appointment
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 12 Oct 2010
Synosia Therapeutics Raises $30M in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Oct 2010
New Leaf Venture Partners Invests in $35.4 (£22.4) Million Series A Financing of Convergence Pharmaceuticals
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Sep 2010
ArthroCare Introduces Complete Ambient ArthroWand Collection
Devices Orthopaedic
 HSMN NewsFeed - 27 Sep 2010
TetraLogic Expands Series C Financing with New Investor Pfizer Ventures
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Sep 2010
ArthroCare Receives FDA Clearance for Parallax Contour Vertebral Augmentation Device
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 20 Sep 2010
NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 Sep 2010
Lantos Technologies Closes on $1.6 Million Series A Financing to Support Development of World's First Real-Time 3D Ear Canal Scanning Technology
Devices Venture Capital
 HSMN NewsFeed - 13 Sep 2010
Roche Receives FDA Clearance for U.S. Launch of cobas 8000 Modular Analyzer Series for High-Volume Laboratory Testing
Devices Diagnostics FDA
 HSMN NewsFeed - 13 Sep 2010
Relypsa Raises $70 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Aug 2010
Otonomy Closes $38.5 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Aug 2010
Gemin X Closes $8 Million Series E Financing
Biopharmaceuticals Venture Capital Oncology
 HSMN NewsFeed - 29 Jul 2010
ZOLL AED Plus and AED Pro Approved by Japan Medical Device Safety Division and Office of Medical Devices
Devices Cardiology Regulatory
 HSMN NewsFeed - 26 Jul 2010
Immune Design Corp. Raises $32 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jul 2010
Integrated Diagnostics Secures $10 Million Second Tranche of Series A Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 21 Jul 2010
Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jul 2010
iPierian Closes $22 Million Series B Financing Led By Google Ventures
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 7 Jul 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2010
Calistoga Pharmaceuticals Raises $40 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jun 2010
AqueSys, Inc. Closes $35M Series C Round
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 22 Jun 2010
Baxano, Inc. Announces Close of $30 Million Series C Funding
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 16 Jun 2010
Predictive Biosciences Closes $25 Million Series C Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 11 Jun 2010
KV Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2010
Anulex Technologies, Inc. to Raise a Minimum of $20 Million in Series E Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 2 Jun 2010
Constellation Pharmaceuticals Closes $22 Million in Series B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Jun 2010
Tetraphase Closes $45 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 May 2010
Logical Therapeutics Secures $16.9M Series C Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 May 2010
Tryton Announces Positive Data from Side Branch System Presented in Symposium at EuroPCR 2010
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2010
Roche and Biogen Idec Announce Their Decision to Discontinue the ocrelizumab Clinical Development Programme in Patients with Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2010
New Studies Presented at Digestive Disease Week Highlight the Value of PillCam(R) Capsule Endoscopy
Devices Gastroenterology
 HSMN NewsFeed - 20 Apr 2010
Gemin X Announces $16 Million Series D Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 Apr 2010
Selecta Closes $15 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Mar 2010
Promedior Closes $12 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Feb 2010
Pfizer Receives FDA Approval for Prevnar 13 for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Feb 2010
MicroTransponder Raises $10 Million to Begin Clinical Trials of Wireless Neurostimulation for Chronic Pain and Obtain FDA Clearance
Devices Venture Capital Personnel
 HSMN NewsFeed - 3 Feb 2010
Viroblock SA Hires Dr. Jamie Paterson as CEO and Closes Financing Round
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 2 Feb 2010
Journal of American College of Cardiology Publishes Study Demonstrating Safety & Effectiveness of Laser Assisted Lead Removal
Devices Cardiology
 HSMN NewsFeed - 28 Jan 2010
Ligand Completes Acquisition of Metabasis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Jan 2010
Neomend Completes $30M Funding with Clarus Ventures, Other Investors
Devices Surgery Venture Capital
 HSMN NewsFeed - 19 Jan 2010
Liquidia Technologies Raises $20 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Jan 2010
VentiRx Pharmaceuticals Raises $25 Million in Series A Extension Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jan 2010
Santé Ventures Invests $2.6MM in TVA Medical
Devices Venture Capital
 HSMN NewsFeed - 5 Jan 2010
CircuLite(R) Closes on Series C Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 4 Jan 2010
ArthroCare Names Scott Schaffner Senior Vice President and General Manager of Sports Medicine
Devices Personnel
 HSMN NewsFeed - 30 Dec 2009
ZOLL Receives FDA Clearance to Market E Series Defibrillators with Carbon Monoxide Monitoring
Devices Monitoring FDA
 HSMN NewsFeed - 16 Dec 2009
Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Dec 2009
Epizyme Closes $40M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Dec 2009
Zogenix Increases Series B Preferred Stock Financing to $71 Million, Raising $35 Million in Second Tranche
Biopharmaceuticals Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 23 Nov 2009
Receptos Completes $25M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Nov 2009
Entellus Medical(R) Secures $30 Million Financing To Expand Commercialization of Novel Treatments for Sinusitis
Devices Venture Capital
 HSMN NewsFeed - 26 Oct 2009
ArthroCare Names David Fitzgerald President and CEO
Devices Personnel
 HSMN NewsFeed - 13 Oct 2009
CalciMedica Appoints Evelyn Graham to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2009
Transenterix Secures $55 Million in Financing
Devices Surgery Venture Capital
 HSMN NewsFeed - 8 Oct 2009
BMEYE B.V. Completes EUR 6 Million Series B Financing Round
Devices Monitoring Venture Capital
 HSMN NewsFeed - 7 Oct 2009
Epizyme Closes $32 Million Series B Financing, Led by New Investor Bay City Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Oct 2009
TechniScan Medical Systems Closes Series E Financing Totaling $6M
Devices Venture Capital
 HSMN NewsFeed - 16 Sep 2009
PharmAbcine Closes USD $6 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Sep 2009
Alvine Pharmaceuticals Raises $21.5 Million Series A Extension
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Sep 2009
Endosense Closes USD 36 Million / Euro 25 Million Series B Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 18 Aug 2009
Adamas Pharmaceuticals Raises $40 Million in Series D Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 14 Aug 2009
Embrella Cardiovascular, Inc. Announces Final Closing of Series B Round
Devices Interventional Venture Capital
 HSMN NewsFeed - 22 Jul 2009
Profectus Biosciences Secures $5M in Series C Venture Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Jul 2009
BeneChill Raises $13.5 Million Series C
Devices Venture Capital
 HSMN NewsFeed - 8 Jul 2009
Allostera Pharma Inc. Closes $17M (CAD) Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jul 2009
Rapid Micro Biosystems Closes $18.6M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jun 2009
Small Bone Innovations, Inc. Raises $144 Million
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 30 Jun 2009
Hyperion Therapeutics Raises $60 Million Series C
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jun 2009
CoAxia, Inc. Announces $21.5M Series D Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 8 Jun 2009
Inspire Medical Systems Completes $17 Million Series B Financing
Devices Venture Capital
 HSMN NewsFeed - 2 Jun 2009
miRagen Therapeutics, Inc. Accomplishes Funding Milestones and Secures Series A Extension
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 May 2009
Aragon Pharmaceuticals Announces $8 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 May 2009
Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 May 2009
Cempra Pharmaceuticals Closes $46 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Apr 2009
PhotoThera Closes $50 Million Financing, Announces New President and Chief Executive Officer
Devices Neurology Venture Capital Personnel
 HSMN NewsFeed - 16 Apr 2009
Lycera Closes $36 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Apr 2009
Marinus Pharmaceuticals Raises $20 Million in Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 7 Apr 2009
PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)
Devices Surgery
 HSMN NewsFeed - 6 Apr 2009
Cerapedics Closes $15 Million Series B Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 26 Mar 2009
Neuraltus Pharmaceuticals Raises $17 Million Series A Funding
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 18 Feb 2009
NanoBio Corporation Raises $12 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Feb 2009
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 13 Feb 2009
MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series
Devices Wound Care
 HSMN NewsFeed - 28 Jan 2009
The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company
Devices Venture Capital Personnel
 HSMN NewsFeed - 26 Jan 2009
KV Pharmaceutical Suspends Product Manufacturing, Shipping
Biopharmaceuticals Product Recall FDA
 HSMN NewsFeed - 22 Jan 2009
Ottawa Paramedic Service Awards ZOLL a Third Contract as Preferred Vendor for Defibrillators
Devices
 HSMN NewsFeed - 22 Jan 2009
Zoll Receives Clearance to Market New R Series BLS and R Series Plus Defibrillators
Devices FDA
 HSMN NewsFeed - 16 Jan 2009
Avantis Medical Systems, Inc. Raises $10 Million in Series C Funding
Devices Gastroenterology Oncology Venture Capital
 HSMN NewsFeed - 16 Jan 2009
Hydra Biosciences Raises $22 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jan 2009
Arbor Pharmaceuticals Announces Closing of Series A Financing and Initial Deployment of the Company's Pediatric Sales Force
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Dec 2008
Basilea Pharmaceutica opens U.S. phase III study on alitretinoin for the treatment of severe chronic hand eczema
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 16 Dec 2008
Pioneer(R) Surgical Technology, Inc. Closes $15 Million Series B Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 15 Dec 2008
Santé Ventures Announces $5.5 MM Investment in BioStable
Devices Cardiology Venture Capital
 HSMN NewsFeed - 12 Dec 2008
Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 2 Dec 2008
Caroline Loewy Joins Corcept as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2008
Tengion Announces Second Closing of Series C Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 13 Nov 2008
ZOLL ENTERS MULTI-YEAR AGREEMENT TO ADD MASIMO RAINBOW SET TECHNOLOGY IN E SERIES DEFIBRILLATORS
Devices Cardiology
 HSMN NewsFeed - 5 Nov 2008
AMDL, Inc. Names Douglas MacLellan as Executive Chairman & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2008
CeNeRx BioPharma Completes $15 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Oct 2008
Micronics Completes Series C Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 16 Oct 2008
Predictive Biosciences Closes $21.75 Million in Series B Financing
Diagnostics Venture Capital
Return to NewsFeed  

 Additional items found! 127

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 127 additional stories matching:
E Series
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.